文献速递分子诊断临床微生物质量管理与危急值

实验室自建核酸扩增检测诊断肺结核与肺外结核的性能与应用

Performance and Utilization of a Laboratory-Developed Nucleic Acid Amplification Test (NAAT) for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in a Low-Prevalence Area.
PubMed 文献 · Am J Clin Pathol · 2020-01-01

该研究在低流行地区回顾性比较实验室自建TBPCR(靶向MTBC IS6110)与涂片、培养对肺结核和肺外结核的诊断价值,纳入146例培养阳性患者。TBPCR检出88.4%结核(涂片阳性97%、涂片阴性79%),特异性100%;但仅57%肺结核和33%肺外结核患者使用该检测,存在明显未充分利用。

要点

  • TBPCR总检出率88.4%,涂片阳性97%、涂片阴性79%,特异性100%。
  • TBPCR在肺结核中仅57%、肺外结核中仅33%患者使用,明显不足。
  • TBPCR阴性肺结核(P = .002)和肺外结核(P < .008)提示细菌载量低。

核心结论

  • TBPCR性能理想但使用显著不足,作者建议制定强制使用TBPCR的指南以覆盖临床疑似肺结核患者。

主要发现

  • TBPCR用于57%的肺结核患者和33%的肺外结核患者。
  • TBPCR检出88.4%的所有结核(涂片阳性97%、涂片阴性79%),特异性100%。
  • TBPCR阴性肺结核(P = .002)和肺外结核(P < .008)提示细菌载量低。

临床怎么用

  • 在低流行人群中聚焦使用TBPCR,可加快治疗启动并有益于感染防控和公共卫生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Tuberculosis (TB) is a significant global health problem. In low-prevalence areas and low clinical suspicion, nucleic acid amplification tests (NAAT) for direct detection of Mycobacterium tuberculosis complex (MTBC) can speed therapy initiation and infection control. An NAAT assay (TBPCR) targeting MTBC IS6110 is used for detecting MTBC in our low-prevalence population. METHODS: Fifteen-year review of patient records identified 146 patients with culture-positive pulmonary tuberculosis (PTB) or extrapulmonary tuberculosis (EPTB). Laboratory-developed TBPCR was retrospectively compared with standard stain and cultures for PTB and EPTB diagnoses. RESULTS: TBPCR assay was used in 57% of patients with PTB and 33% of patients with EPTB. TBPCR detected 88.4% of all TB (smear-positive, 97%; smear-negative, 79%) with 100% specificity. Low bacterial load was indicated in TBPCR-negative PTB (P = .002) and EPTB (P < .008). CONCLUSIONS: TBPCR performance was optimum but significantly underused. Guidelines are proposed for mandated use of TBPCR that capture patients with clinically suspected PTB. Focused TBPCR use in low prevalence populations will benefit patient care, infection prevention, and public health.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. Das S, Mangold KA, Shah NS, et al. Performance and Utilization of a Laboratory-Developed Nucleic Acid Amplification Test (NAAT) for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in a Low-Prevalence Area. Am J Clin Pathol. 2020. PMID: 32249294. doi:10.1093/ajcp/aqaa031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。